StonvexLoading…
StonvexStonvexStonvexCore line items from GOSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $48.47M | $114.70M | $0.00 | $0.00 |
Operating Income | $-170.73M | $-59.92M | $-183.76M | $-218.59M |
Net Income | $-170.37M | $-56.53M | $-179.82M | $-229.38M |
EPS (Diluted) | $-0.75 | $-0.25 | $-1.18 | $-2.71 |
Total Assets | $172.25M | $315.29M | $311.92M | $272.45M |
Total Liabilities | $295.01M | $285.80M | $249.15M | $260.37M |
Cash & Equivalents | $37.73M | $46.07M | $32.11M | $111.97M |
Free Cash Flow OCF − CapEx | $-171.34M | $-3.47M | $-159.16M | $-187.44M |
Shares Outstanding | 233.68M | 226.60M | 225.41M | 94.42M |